Bristol-Myers Squibb Co

詳細情報 Bristol-Myers Squibb Co 企業名

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.

企業情報

企業コードBMY

会社名Bristol-Myers Squibb Co

上場日Mar 17, 1980

最高経営責任者「CEO」Dr. Christopher S. (Chris) Boerner, Ph.D.

従業員数34100

証券種類Ordinary Share

決算期末Mar 17

本社所在地Route 206 And Province Line Road

都市PRINCETON

証券取引所NYSE Consolidated

国United States of America

郵便番号08543

電話番号16092524621

ウェブサイトhttps://www.bms.com

企業コードBMY

上場日Mar 17, 1980

最高経営責任者「CEO」Dr. Christopher S. (Chris) Boerner, Ph.D.

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Christopher S. (Chris) Boerner, Ph.D.

Chairman of the Board, Chief Executive Officer

62.72K

-50.00%

Ms. Karin Shanahan

Executive Vice President, Global Product Development & Supply, Member of the Leadership Team

16.70K

+10.70%

Dr. Julia A. Haller, M.D.

Independent Director

13.62K

--

Mr. Adam Lenkowsky

Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team

12.44K

+87.05%

Ms. Cari Gallman

Executive Vice President, General Counsel and Chief Policy Officer

8.84K

+6.22%

Dr. Manuel Hidalgo Medina, M.D., Ph.D.

Independent Director

--

Mr. Derica W. Rice

Independent Director

--

Ms. Lynelle Hoch

President, Cell Therapy Organization, Member of the Leadership Team

--

Dr. Deepak L. Bhatt, M.D.

Independent Director

--

Mr. Phil Holzer

Senior Vice President, Controller

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Christopher S. (Chris) Boerner, Ph.D.

Chairman of the Board, Chief Executive Officer

62.72K

-50.00%

Ms. Karin Shanahan

Executive Vice President, Global Product Development & Supply, Member of the Leadership Team

16.70K

+10.70%

Dr. Julia A. Haller, M.D.

Independent Director

13.62K

--

Mr. Adam Lenkowsky

Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team

12.44K

+87.05%

Ms. Cari Gallman

Executive Vice President, General Counsel and Chief Policy Officer

8.84K

+6.22%

Dr. Manuel Hidalgo Medina, M.D., Ph.D.

Independent Director

--

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

事業別USD

会社名

収益

比率

Eliquis

3.56B

31.83%

Opdivo

2.27B

20.30%

Revlimid

936.00M

8.36%

Orencia

770.00M

6.87%

Pomalyst/Imnovid

659.00M

5.88%

Other

3.00B

26.76%

地域別USD

会社名

収益

比率

United States

7.87B

70.29%

International

3.11B

27.77%

other

218.00M

1.95%

事業別

地域別

事業別USD

会社名

収益

比率

Eliquis

3.56B

31.83%

Opdivo

2.27B

20.30%

Revlimid

936.00M

8.36%

Orencia

770.00M

6.87%

Pomalyst/Imnovid

659.00M

5.88%

Other

3.00B

26.76%

株主

更新時刻: Tue, Aug 12

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

9.53%

BlackRock Institutional Trust Company, N.A.

4.88%

State Street Global Advisors (US)

4.66%

Charles Schwab Investment Management, Inc.

3.48%

JP Morgan Asset Management

3.31%

Other

74.14%

株主統計

比率

The Vanguard Group, Inc.

9.53%

BlackRock Institutional Trust Company, N.A.

4.88%

State Street Global Advisors (US)

4.66%

Charles Schwab Investment Management, Inc.

3.48%

JP Morgan Asset Management

3.31%

Other

74.14%

種類

株主統計

比率

Investment Advisor

47.07%

Investment Advisor/Hedge Fund

24.03%

Research Firm

3.15%

Pension Fund

2.45%

Bank and Trust

2.19%

Sovereign Wealth Fund

1.84%

Hedge Fund

0.60%

Insurance Company

0.20%

Family Office

0.06%

Other

18.42%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

4180

1.70B

83.46%

+31.40M

2025Q1

4287

1.68B

82.63%

+10.66M

2024Q4

4261

1.65B

81.14%

+17.04M

2024Q3

4116

1.60B

78.69%

-22.73M

2024Q2

4105

1.59B

78.35%

-83.12M

2024Q1

4118

1.64B

80.97%

+13.32M

2023Q4

4115

1.60B

78.83%

-46.39M

2023Q3

4042

1.63B

77.83%

-55.50M

2023Q2

4082

1.66B

78.77%

-34.93M

2023Q1

4110

1.66B

78.74%

-34.09M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

190.47M

9.36%

+1.45M

+0.77%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

97.77M

4.8%

+752.85K

+0.78%

Mar 31, 2025

State Street Global Advisors (US)

94.83M

4.66%

-310.27K

-0.33%

Mar 31, 2025

Charles Schwab Investment Management, Inc.

60.61M

2.98%

+306.43K

+0.51%

Mar 31, 2025

JP Morgan Asset Management

69.89M

3.43%

+6.79M

+10.76%

Mar 31, 2025

Capital International Investors

66.47M

3.27%

+20.60M

+44.91%

Mar 31, 2025

Geode Capital Management, L.L.C.

45.45M

2.23%

+1.06M

+2.39%

Mar 31, 2025

Norges Bank Investment Management (NBIM)

35.18M

1.73%

+2.58M

+7.92%

Dec 31, 2024

Columbia Threadneedle Investments (US)

29.03M

1.43%

+534.70K

+1.88%

Mar 31, 2025

Wellington Management Company, LLP

23.73M

1.17%

+17.75M

+296.96%

Mar 31, 2025

詳細を見る

関連ETF

更新時刻: Wed, Aug 6

銘柄名

比率

First Trust NASDAQ Pharmaceuticals ETF

5.91%

LSV Disciplined Value ETF

4.06%

iShares U.S. Pharmaceuticals ETF

3.88%

Coastal Compass 100 ETF

3.81%

Schwab U.S. Dividend Equity ETF

3.57%

Cullen Enhanced Equity Income ETF

3.33%

SPDR S&P Pharmaceuticals ETF

3.26%

Tema Oncology ETF

3.16%

VanEck Pharmaceutical ETF

3.1%

Brookstone Value Stock ETF

3%

詳細を見る

First Trust NASDAQ Pharmaceuticals ETF

比率5.91%

LSV Disciplined Value ETF

比率4.06%

iShares U.S. Pharmaceuticals ETF

比率3.88%

Coastal Compass 100 ETF

比率3.81%

Schwab U.S. Dividend Equity ETF

比率3.57%

Cullen Enhanced Equity Income ETF

比率3.33%

SPDR S&P Pharmaceuticals ETF

比率3.26%

Tema Oncology ETF

比率3.16%

VanEck Pharmaceutical ETF

比率3.1%

Brookstone Value Stock ETF

比率3%

配当金

過去5年間の配当金総支払額は 22.71B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Dec 11, 2024

BMY.NB Interim Cash Dividend of gross USD 0.62 paid on Feb 03, 2025 going ex on Jan 03, 2025 with reinvestment option

Jan 03, 2025

Feb 03, 2025

Jan 03, 2025

Sep 10, 2024

BMY.NB Final Cash Dividend of gross USD 0.6 paid on Nov 01, 2024 going ex on Oct 04, 2024 with reinvestment option

Oct 04, 2024

Nov 01, 2024

Oct 04, 2024

Jun 18, 2024

BMY.NB Interim Cash Dividend of gross USD 0.6 paid on Aug 01, 2024 going ex on Jul 05, 2024 with reinvestment option

Jul 05, 2024

Aug 01, 2024

Jul 05, 2024

Mar 01, 2024

BMY.NB Interim Cash Dividend of gross USD 0.6 paid on May 01, 2024 going ex on Apr 04, 2024 with reinvestment option

Apr 05, 2024

May 01, 2024

Apr 04, 2024

Dec 06, 2023

BMY.NB Interim Cash Dividend of gross USD 0.6 paid on Feb 01, 2024 going ex on Jan 04, 2024 with reinvestment option

Jan 05, 2024

Feb 01, 2024

Jan 04, 2024

Sep 20, 2023

BMY.NB Final Cash Dividend of gross USD 0.57 paid on Nov 01, 2023 going ex on Oct 05, 2023

Oct 06, 2023

Nov 01, 2023

Oct 05, 2023

Jun 14, 2023

BMY.NB Interim Cash Dividend of gross USD 0.57 paid on Aug 01, 2023 going ex on Jul 06, 2023 with reinvestment option

Jul 07, 2023

Aug 01, 2023

Jul 06, 2023

Mar 03, 2023

BMY.NB Interim Cash Dividend of gross USD 0.57 paid on May 01, 2023 going ex on Apr 06, 2023

Apr 10, 2023

May 01, 2023

Apr 06, 2023

Dec 08, 2022

BMY.NB Interim Cash Dividend of gross USD 0.57 paid on Feb 01, 2023 going ex on Jan 05, 2023

Jan 06, 2023

Feb 01, 2023

Jan 05, 2023

Sep 14, 2022

BMY.NB Final Cash Dividend of gross USD 0.54 paid on Nov 01, 2022 going ex on Oct 06, 2022

Oct 07, 2022

Nov 01, 2022

Oct 06, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

46.550USD

Bristol-Myers Squibb Co

46.550

概要

企業名

金融